Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2

被引:189
|
作者
Lekcharoensuk, P
Morozov, I
Paul, PS
Thangthumniyom, N
Wajjawalku, W
Meng, XJ
机构
[1] Virginia Polytech Inst & State Univ, Ctr Mol Med & Infect Dis, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA
[2] Kasetsart Univ, Dept Microbiol & Immunol, Bangkok, Thailand
[3] Kasetsart Univ, Dept Pathol, Bangkok, Thailand
[4] Kasetsart Univ, Fac Med Vet, Bangkok, Thailand
[5] Ft Dodge Anim Hlth, Ft Dodge, IA USA
[6] Univ Nebraska, Dept Vet Sci, Lincoln, NE 68583 USA
关键词
D O I
10.1128/JVI.78.15.8135-8145.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type 2 porcine circovirus (PCV2) is associated with postweaning multisystemic wasting syndrome in pigs, whereas the genetically related type 1 PCV (PCV1) is nonpathogenic. In this study, seven monoclonal antibodies (MAbs) against PCV2-ORF2 capsid protein were generated, biologically characterized, and subsequently used to map the antigenic sites of PCV2 capsid protein by using infectious PCV DNA clones containing PCV1/PCV2-ORF2 chimeras. The PCV1/PCV2-ORF2 chimeras were constructed by serial deletions of PCV2-ORF2 and replacement with the corresponding sequences of the PCV1-ORF2. The reactivities of chimeric PCV1/PCV2 clones in transfected PK-15 cells with the seven MAbs were detected by an immunofluorescence assay (IFA). The chimera (r140) with a deletion of 47 amino acids at the N terminus of PCV2-ORF2 reacted strongly to all seven MAbs. Expanding the deletion of PCV2-ORF2 from residues 47 to 57 (r175) abolished the recognition of MAb 3B7, 3C11, 4A10, 6H2, or 8F6 to the chimera. Further deletion of PCV2-ORF2 to 62 residues disrupted the binding of this chimera to all seven MAbs. IFA reactivities with all MAbs were absent when residues 165 to 233 at the C terminus of PCV2-ORF2 was replaced with that of PCV1-ORF2. Extending the sequence of PCV2-ORF2 from residues 165 (r464) to 185 (626), 200 (r588), or 224 (r652) restored the ability of the three chimeras to react with MAbs 3C11, 6H2, 9H7, and 12G3 but not with 8F6, 3B7, or 4A10. When the four amino acids at the C terminus of r588 were replaced with that of PCV2-ORF2, the resulting chimera (r588F) reacted with all seven MAbs. The results from this study suggest that these seven MAbs recognized at least five different but overlapping conformational epitopes within residues 47 to 63 and 165 to 200 and the last four amino acids at the C terminus of the PCV2 capsid protein.
引用
收藏
页码:8135 / 8145
页数:11
相关论文
共 50 条
  • [11] Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge
    Seo, Hwi Won
    Park, Changhoon
    Han, Kiwon
    Chae, Chanhee
    VETERINARY RESEARCH, 2014, 45
  • [12] Experimental inoculation of porcine circoviruses type 1 (PCV1) and type 2 (PCV2) in rabbits and mice
    Quintana, J
    Balasch, M
    Segalés, J
    Calsamiglia, M
    Rodríguez-Arrioja, GM
    Plana-Durán, J
    Domingo, M
    VETERINARY RESEARCH, 2002, 33 (03) : 229 - 237
  • [13] Epidemiology and transmission of porcine circovirus type 2 (PCV2)
    Rose, Nicolas
    Opriessnig, Tanja
    Grasland, Beatrice
    Jestin, Andre
    VIRUS RESEARCH, 2012, 164 (1-2) : 78 - 89
  • [14] Porcine Circovirus type 2 (PCV2) associated diseases
    Petrini, S.
    Paniccia, M.
    Gavaudan, S.
    Simoni, E.
    Sensi, M.
    Filipponi, G.
    Rigotti, L.
    Fortunati, M.
    Ferrari, M.
    De Mia, G. M.
    LARGE ANIMAL REVIEW, 2011, 17 (03): : 89 - 98
  • [15] Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo
    Fenaux, M
    Opriessnig, T
    Halbur, PG
    Elvinger, F
    Meng, XJ
    JOURNAL OF VIROLOGY, 2004, 78 (24) : 13440 - 13446
  • [16] Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae
    Opriessnig, T.
    Madson, D. M.
    Schalk, S.
    Brockmeier, S.
    Shen, H. G.
    Beach, N. M.
    Meng, X. J.
    Baker, R. B.
    Zanella, E. L.
    Halbur, P. G.
    THERIOGENOLOGY, 2011, 76 (02) : 351 - 360
  • [17] A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines
    Meggan Bandrick
    Monica Balasch
    Andrea Heinz
    Lucas Taylor
    Vickie King
    Jeri Toepfer
    Dennis Foss
    Veterinary Research, 53
  • [18] Differential Effects of Porcine Circovirus Type 2 (PCV2) Vaccination on PCV2 Genotypes at Japanese Pig Farms
    Takahagi, Yoichi
    Toki, Shinji
    Nishiyama, Yasutaka
    Morimatsu, Fumiki
    Murakami, Hiroshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2010, 72 (01): : 35 - 41
  • [19] Production of virus-like particles of porcine circovirus type 2 (PCV2) capsid protein in yeast and their employment for generation of PCV2-specific monoclonal antibodies and PCV2 diagnostics
    Gedvilaite, A.
    Nainys, J.
    Lasickiene, R.
    Petraityte-Burneikiene, R.
    Lelesius, R.
    Sereika, V.
    Zvirbliene, A.
    Sasnauskas, K.
    FEBS JOURNAL, 2014, 281 : 416 - 417
  • [20] A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines
    Bandrick, Meggan
    Balasch, Monica
    Heinz, Andrea
    Taylor, Lucas
    King, Vickie
    Toepfer, Jeri
    Foss, Dennis
    VETERINARY RESEARCH, 2022, 53 (01) : 12